Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1/A IPO registration
- 4.11 Form of Series a Common Warrant
- 4.12 Form of Series B Common Stock Purchase Warrant
- 5.1 Opinion of Arentfox Schiff, LLP
- 10.22 Form of Securities Purchase Agreement
- 23.1 Consent of Independent Registered Public Accounting Firm
- EX-FILING FEES Calculation of Filing Fee Table
- Download Excel data file
- View Excel data file
Associated filings
CNSP similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in this Registration Statement on Form S-1 (Amendment No. 2) of our report dated March 31, 2023 with respect to the audited financial statements of CNS Pharmaceuticals, Inc. for the years ended December 31, 2022 and 2021. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the references to us under the heading “Experts” in such Registration Statement.
/s/ MaloneBailey, LLP
www.malonebailey.com
Houston, Texas
January 21, 2024